Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer

Su,Chen; Li,Daojiang; Li,Nanpeng; Du,Yuheng; Yang,Chunxing; Bai,Yang; Lin,Changwei; Li,Xiaorong; Zhang,Yi

doi:10.3892/ijo.2018.4305

Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer

Authors:
- Chen Su
- Daojiang Li
- Nanpeng Li
- Yuheng Du
- Chunxing Yang
- Yang Bai
- Changwei Lin
- Xiaorong Li
- Yi Zhang
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
Published online on: March 6, 2018 https://doi.org/10.3892/ijo.2018.4305
Pages: 1479-1490
Copyright: © Su et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pleomorphic adenoma gene like-2 (PLAGL2) is a zinc finger protein transcription factor, which is upregulated and serves an oncogenic function in multiple human malignancies, including colorectal cancer (CRC). First, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression levels of PLAGL2 in CRC tissues and normal tissues. Then, bioinformatics analysis, RT-qPCR, western blotting, luciferase reporter assays and RNA-binding protein immunoprecipitation assays were performed to explore whether the underlying mechanisms, including copy number variation (CNV), microRNAs (miRNAs/miRs) and RNA-binding proteins (RBPs) led to the abnormal expression of PLAGL2. Finally, cell counting kit-8 assays, Transwell assays and xenograft models were used to detect carcinogenesis-associated characteristics based on the 3'-untranslated region (3'-UTR) of PLAGL2. In the present study, PLAGL2 was revealed to be upregulated in CRC tissues compared with normal CRC tissues. CNV was one of the causes leading to the upregulation of PLAGL2. miRNA, including downregulated miR-486-5p, and RBPs, including upregulated human antigen R (HuR), were other key underlying causes. In addition, PLAGL2 3'-UTR was revealed to promote the progression of CRC in vitro and in vivo, and to regulate the expression of C-MYC and CD44. To conclude, these results suggested that high expression of PLAGL2 in CRC was associated with CNV, miR-486-5p and HuR expression, whose 3'-UTR may promote colon carcinogenesis and serve as a novel potential biomarker for CRC therapies.

View Figures

View References

1	Wezensky SJ, Hanks TS, Wilkison MJ, Ammons MC, Siemsen DW and Gauss KA: Modulation of LAGL2 trans-activation by positive cofactor 2 (C2), a component of the ARC/Mediator complex. Gene. 452:22–34. 2010. View Article : Google Scholar
2	Kas K, Voz ML, Hensen K, Meyen E and Van de Ven WJ: Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem. 273:23026–23032. 1998. View Article : Google Scholar : PubMed/NCBI
3	Furukawa T, Adachi Y, Fujisawa J, Kambe T, Yamaguchi-Iwai Y, Sasaki R, Kuwahara J, Ikehara S, Tokunaga R and Taketani S: Involvement of LAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines. Oncogene. 20:4718–4727. 2001. View Article : Google Scholar : PubMed/NCBI
4	Van Dyck F, Declercq J, Braem CV and Van de Ven WJ: LAG1 the prototype of the PLAG gene family: Versatility in tumour development (Review). Int J Oncol. 30:765–774. 2007.PubMed/NCBI
5	Hanks TS and Gauss KA: Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73 and induces cell cycle block and apoptosis in human promonocytic U937 cells. Apoptosis. 17:236–247. 2012. View Article : Google Scholar
6	Zheng H, Ying H, Wiedemeyer R, Yan H, Quayle SN, Ivanova EV, Paik JH, Zhang H, Xiao Y, Perry SR, et al: LAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 17:497–509. 2010. View Article : Google Scholar : PubMed/NCBI
7	Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, Delwel R and Castilla LH: Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood. 105:2900–2907. 2005. View Article : Google Scholar
8	Yang YS, Yang MC and Weissler JC: Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema. Lung Cancer. 74:12–24. 2011. View Article : Google Scholar : PubMed/NCBI
9	Liu B, Lu C, Song YX, Gao P, Sun JX, Chen XW, Wang MX, Dong YL, Xu HM and Wang ZN: The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. Int J Clin Exp Pathol. 7:3089–3100. 2014.PubMed/NCBI
10	Wang YP, Guo PT, Zhu Z, Zhang H, Xu Y, Chen YZ, Liu F and Ma SP: Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma. Oncol Rep. 37:1961–1970. 2017. View Article : Google Scholar : PubMed/NCBI
11	Li DJ, Lin CW, Chen M, Li NP, Du YH, Su C, Yang CX, Gong N, Wu H, Wu RL, et al: Comprehensive bioinformatics analysis of the characterization and determination underlying mechanisms of over-expression and co-expression of genes residing on 20q in colorectal cancer. Oncotarget. 8:78642–78659. 2017.PubMed/NCBI
12	Liang L, Fang JY and Xu J: Gastric cancer and gene copy number variation: Emerging cancer drivers for targeted therapy. Oncogene. 35:1475–1482. 2016. View Article : Google Scholar
13	Yang Z, Zhuan B, Yan Y, Jiang S and Wang T: Integrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinoma. Biol Res. 48:472015. View Article : Google Scholar : PubMed/NCBI
14	Mercer TR, Wilhelm D, Dinger ME, Soldà G, Korbie DJ, Glazov EA, Truong V, Schwenke M, Simons C, Matthaei KI, et al: Expression of distinct RNAs from 3′ untranslated regions. Nucleic Acids Res. 39:2393–2403. 2011. View Article : Google Scholar
15	Rutnam ZJ and Yang BB: The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci. 125:2075–2085. 2012. View Article : Google Scholar : PubMed/NCBI
16	Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, et al: Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 27:907–919. 2013. View Article : Google Scholar
17	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
18	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
19	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007. View Article : Google Scholar
20	Liu C, Li M, Hu Y, Shi N, Yu H, Liu H and Lian H: miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma. Onco Targets Ther. 9:2865–2871. 2016.PubMed/NCBI
21	Lebedeva S, Jens M, Theil K, Schwanhäusser B, Selbach M, Landthaler M and Rajewsky N: Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell. 43:340–352. 2011. View Article : Google Scholar : PubMed/NCBI
22	Brennan CM and Steitz JA: HuR and mRNA stability. Cell Mol Life Sci. 58:266–277. 2001. View Article : Google Scholar
23	Abdelmohsen K and Gorospe M: Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA. 1:214–229. 2010. View Article : Google Scholar
24	Kotta-Loizou I, Giaginis C and Theocharis S: Clinical significance of HuR expression in human malignancy. Med Oncol. 31:1612014. View Article : Google Scholar : PubMed/NCBI
25	Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, Carter NP, Hurles ME and Feuk L: Challenges and standards in integrating surveys of structural variation. Nat Genet. 39(Suppl 7): S7–S15. 2007. View Article : Google Scholar : PubMed/NCBI
26	Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B, et al: Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer. 12:502012. View Article : Google Scholar : PubMed/NCBI
27	de Souza CR, Leal MF, Calcagno DQ, Costa Sozinho EK, Borges BN, Montenegro RC, Dos Santos AK, Dos Santos SE, Ribeiro HF, Assumpção PP, et al: MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One. 8:e644202013. View Article : Google Scholar : PubMed/NCBI
28	Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, Wangsa D, Hummon AB, Grade M, Ried T and Difilippantonio MJ: Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer. 48:1002–1017. 2009. View Article : Google Scholar : PubMed/NCBI
29	Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, et al: TNFRSF10C copy number variation is associated with metastatic colorectal cancer. J Gastrointest Oncol. 7:306–314. 2016. View Article : Google Scholar : PubMed/NCBI
30	Kuersten S and Goodwin EB: The power of the 3′ UTR: Translational control and development. Nat Rev Genet. 4:626–637. 2003. View Article : Google Scholar : PubMed/NCBI
31	Zhang X, Zhang T, Yang K, Zhang M and Wang K: miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition. Onco Targets Ther. 9:6909–6914. 2016. View Article : Google Scholar : PubMed/NCBI
32	Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. 33:1181–1189. 2014. View Article : Google Scholar :
33	Youness RA, El-Tayebi HM, Assal RA, Hosny K, Esmat G and Abdelaziz AI: MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol Lett. 12:2567–2573. 2016. View Article : Google Scholar : PubMed/NCBI
34	Chai Y, Liu J, Zhang Z and Liu L: HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med. 5:1588–1598. 2016. View Article : Google Scholar : PubMed/NCBI
35	Zhang Z, Huang A, Zhang A and Zhou C: HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA. Biomed Pharmacother. 91:788–795. 2017. View Article : Google Scholar : PubMed/NCBI
36	Li J and Lu X: The emerging roles of 3′ untranslated regions in cancer. Cancer Lett. 337:22–25. 2013. View Article : Google Scholar : PubMed/NCBI
37	Wu Q, Yan H, Tao SQ, Wang XN, Mou L, Chen P, Cheng XW, Wu WY and Wu ZS: XIAP 3′-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 8:16784–16800. 2017.PubMed/NCBI
38	Garte SJ: The c-myc oncogene in tumor progression. Crit Rev Oncog. 4:435–449. 1993.PubMed/NCBI
39	Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, et al: CD44 is of functional importance for colorectal cancer stem cells. Clinical cancer research: an official journal of the American Association for Cancer Research. 14:6751–6760. 2008. View Article : Google Scholar